425: Vireo Growth Discusses Planet 13 Merger & Strong Q2 Results

Vireo Growth Inc. details its strategic merger with Planet 13 Holdings Inc. and reports a substantial 335% year-over-year revenue increase for Q2 2026, exceeding estimates.

Summary

• Vireo Growth Inc. (Vireo) is merging with Planet 13 Holdings Inc. (Planet 13) through its subsidiary, Supernova Merger Sub Inc.
• Sam Armenia, Vireo's Director of Capital Markets, discussed the company's strategy and recent performance in an interview.
• Vireo reported Q2 2026 GAAP revenue of $209.3 million, a 335% increase year-over-year, surpassing Wall Street estimates.
• Pro forma revenue reached $254.9 million, indicating an annualized run rate exceeding $1 billion.
• The company narrowed its net loss to $0.1 million and achieved an Adjusted EBITDA of $41.5 million (19.8% of sales).
• Vireo ended the quarter with $122.7 million in cash.
• The company's M&A strategy focuses on acquiring capital-constrained operators at favorable valuations, not overleveraging the balance sheet.
• Vireo emphasizes a decentralized operational model, allowing acquired brands to maintain their local identity while benefiting from corporate resources.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive development, highlighting strong financial performance and a strategic acquisition that positions the company for significant future growth, despite inherent industry risks.

Positives

• Significant year-over-year revenue growth of 335% in Q2 2026, reaching $209.3 million.
• Pro forma revenue exceeding $1 billion annualized run rate ($254.9 million in Q2).
• Narrowed net loss to $0.1 million.
• Strong Adjusted EBITDA of $41.5 million, representing 19.8% of sales.
• Healthy cash position of $122.7 million at the end of the quarter.
• Strategic merger with Planet 13 Holdings Inc. to expand market reach and scale.
• Acquisition strategy focuses on acquiring distressed or capital-constrained operators at attractive prices, avoiding balance sheet overleveraging.
• Successful integration of acquired companies like Eaze, showing growth post-acquisition.
• Revenue per share increased sequentially by 45% on a GAAP basis and 23% on a pro forma basis, indicating accretive growth.
• Secured an ABL facility with BMO at favorable rates (3% lower than industry average).

Negatives

• Reported a net loss of $0.1 million in Q2 2026, although significantly narrowed.
• The company is still in the process of onboarding and integrating numerous acquisitions, which presents ongoing operational complexity.
• The cannabis industry faces significant regulatory uncertainty and market volatility.
• While revenue per share is growing, the overall market capitalization may not yet reflect the pro forma revenue run rate, suggesting potential undervaluation or market skepticism.

Risks

• Risks related to the receipt of necessary regulatory and third-party approvals for the proposed Merger.
• Vireo's and Planet 13's ability to maintain relationships with suppliers, customers, employees, and other third parties as a result of the proposed Merger.
• The effects of the proposed Merger on Vireo, Planet 13, and the interests of various constituents.
• Potential for pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions.
• Risks related to the timing and content of adult-use legislation in markets where Vireo and Planet 13 operate.
• Federal, state, local, and foreign government laws, rules, and regulations, including those relating to cannabis operations in the United States.
• Liquidity and the ability of Vireo to raise additional financing to continue as a going concern.
• Execution of business strategy and management of growth, with inherent difficulties in forecasting future events.

Future Outlook

Vireo expects to continue its acquisitive strategy, focusing on building a large, cash-generative business. The company anticipates further integration of recent and announced acquisitions and believes the current market multiples present an opportune time for M&A. The company aims to build a Fortune 500 company, not just an MSO, with a focus on efficient capital allocation and strong cash generation.

Management Comments

• "We talk about geez, seven, eight years with C21. So it's definitely you know going from the small little engine that could that you know tried to do everything the right way to you know the fastest growing cannabis operator I would say in the world right now."
• "We're not overleveraging the balance sheet to do this... In a lot of cases, because we're buying capital constrained operators, right? We're not necessarily paying, you know, the full market value to acquire these assets."
• "If you try to apply, you know, any tier one strategy on retail, for instance, you come into Northern Nevada and try to apply that to the three silver state relief stores that do 725,000 transactions. You may like really disrupt that."
• "The number one question over and over again is integration risk, right? And everybody has PTSD about what we've seen in this industry."
• "His vision is to build a smart, efficient capital allocator that is building, you know, the largest. And he doesn't even look at it as cannabis, right? It's ultimately, it's he wants to build a cash generative business."
• "We remain acquisitive, right? Like, we're not. Yeah. You know, John said as much in the q2 news release and on the earnings call, right? We're still heads down trying to continue to build this."
• "The strategy of building an MSO is a thing of the past."
• "We're not building an MSO; we're building a Fortune 500 company."

Industry Context

StockSavvy.ai notes that Vireo's aggressive M&A strategy and focus on acquiring undervalued, capital-constrained operators aligns with a broader trend in the cannabis industry seeking consolidation and operational efficiencies. The company's emphasis on a decentralized model and maintaining local brand identity differentiates it from more centralized MSO approaches, potentially mitigating integration risks and preserving customer loyalty in diverse markets.

Comparison to Industry Standards

• Vireo's pro forma revenue run rate of over $1 billion places it among a select group of large-scale cannabis operators.
• The company's Q2 GAAP revenue growth of 335% significantly outpaces typical growth rates seen in many mature industries, though it is more common in rapidly expanding sectors like cannabis.
• Adjusted EBITDA margins of 19.8% are competitive within the cannabis sector, particularly for companies undergoing rapid expansion.
• The acquisition strategy of purchasing assets at 'pennies on the dollar' from capital-constrained operators contrasts with historical M&A in the cannabis space, which often occurred at peak valuations and with significant leverage (e.g., Origin House, Select, Canamed, Med Relief).
• Vireo's ability to secure institutional debt at rates significantly below typical cannabis industry debt (e.g., ABL facility with BMO at 3% lower than industry average) suggests a higher perceived credit quality compared to many peers.

Legal Proceedings

• Potential for pending and future litigation, other legal or regulatory proceedings, or governmental investigations and actions.
• Information regarding participants in the solicitation of proxies for the Merger will be included in the proxy statement/prospectus.

Stakeholder Impact

• Shareholders: Potential for increased share value through accretive acquisitions and growth, but also subject to integration risks and market volatility.
• Employees: Integration of acquired companies may lead to changes in organizational structure and roles.
• Suppliers and Customers: The merger and ongoing acquisitions aim to maintain relationships while expanding reach and product offerings.
• Creditors: The company's focus on not overleveraging the balance sheet and securing favorable debt terms aims to maintain financial stability.

Next Steps

• Complete the merger with Planet 13 Holdings Inc.
• File a registration statement on Form S-4 with the SEC, including a proxy statement/prospectus.
• Continue to integrate acquired operations and manage growth at scale.
• Continue to pursue acquisitive growth opportunities.
• Focus on building a cash-generative business with the goal of becoming a Fortune 500 company.

Key Dates

Recommendation

The filing details exceptionally strong Q2 2026 financial results, significantly exceeding expectations with robust revenue growth and improved profitability. The strategic merger with Planet 13, coupled with a disciplined M&A approach focused on acquiring undervalued assets and building per-share value, positions Vireo for substantial future growth. The company's ability to secure favorable institutional debt and its clear vision to build a Fortune 500 cash-generative business, rather than a traditional MSO, suggest a compelling investment thesis at current market valuations, despite inherent industry risks.

Keywords

cannabis M&A, Vireo Growth, Planet 13 Holdings, merger, revenue growth, EBITDA, capital markets, dispensaries